Caribou Biosciences, Inc.
CRBU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $25 | $29 | $16 |
| Short-Term Investments | $136 | $159 | $179 | $193 |
| Receivables | $2 | $3 | $3 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $6 | $6 | $7 |
| Total Curr. Assets | $156 | $193 | $217 | $219 |
| Property Plant & Equip (Net) | $24 | $25 | $38 | $39 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $13 | $49 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $16 | $4 | $5 | $6 |
| Total NC Assets | $39 | $28 | $56 | $94 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $195 | $221 | $274 | $313 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $4 | $2 |
| Short-Term Debt | $3 | $2 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $3 | $3 | $3 |
| Other Curr. Liab. | $19 | $21 | $20 | $24 |
| Total Curr. Liab. | $28 | $29 | $28 | $31 |
| LT Debt | $23 | $24 | $24 | $25 |
| Deferred Rev, NC | $2 | $2 | $3 | $3 |
| Deferred Tax Liab, NC | $1 | $1 | $1 | $1 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $25 | $26 | $28 | $30 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $23 | $26 | $26 | $26 |
| Total Liabilities | $53 | $55 | $56 | $60 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$570 | -$542 | -$488 | -$448 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $712 | $709 | $705 | $701 |
| Total Equity | $142 | $166 | $217 | $253 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $195 | $221 | $274 | $313 |
| Net Debt | $14 | $1 | -$3 | $10 |